HealthEquity, Inc. (NASDAQ:HQY) Shares Acquired by BNP Paribas Financial Markets

BNP Paribas Financial Markets boosted its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 165.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 20,437 shares of the company's stock after purchasing an additional 12,745 shares during the period. BNP Paribas Financial Markets' holdings in HealthEquity were worth $1,673,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. International Assets Investment Management LLC bought a new stake in shares of HealthEquity during the second quarter worth $35,000. Paladin Wealth LLC purchased a new position in HealthEquity in the 3rd quarter worth about $39,000. GAMMA Investing LLC lifted its holdings in HealthEquity by 114.8% during the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company's stock valued at $51,000 after buying an additional 318 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in HealthEquity during the 2nd quarter valued at about $73,000. Finally, 1620 Investment Advisors Inc. purchased a new stake in HealthEquity in the 3rd quarter valued at about $112,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Stock Performance

HQY traded down $0.64 during trading on Friday, reaching $100.21. 885,402 shares of the company's stock were exchanged, compared to its average volume of 707,893. HealthEquity, Inc. has a 1 year low of $62.10 and a 1 year high of $105.82. The stock has a market capitalization of $8.75 billion, a P/E ratio of 83.51, a price-to-earnings-growth ratio of 1.61 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The company's fifty day simple moving average is $92.42 and its 200-day simple moving average is $83.61.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft upped their target price on HealthEquity from $102.00 to $103.00 and gave the stock a "buy" rating in a report on Wednesday, September 4th. The Goldman Sachs Group began coverage on shares of HealthEquity in a research note on Friday, November 15th. They issued a "neutral" rating and a $108.00 price objective for the company. JMP Securities reissued a "market outperform" rating and set a $105.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Royal Bank of Canada restated an "outperform" rating and issued a $92.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Finally, Barrington Research increased their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research note on Monday, December 2nd. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $109.64.

Insiders Place Their Bets

In related news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the transaction, the director now directly owns 54,719 shares in the company, valued at approximately $4,540,582.62. This trade represents a 13.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Frank Corvino sold 1,247 shares of the stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total value of $100,084.22. Following the transaction, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. This represents a 20.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 10,536 shares of company stock worth $884,517 in the last three months. 2.20% of the stock is owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.